Serum protein mediators of dementia and aging proper

Aging

Volumn 8, Issue 12, 2016, Pages 3241-3254

  Royall, Donald R ^a,b,c   Al Rubaye, Safa ^a   Bishnoi, Ram ^d   Palmer, Raymond F ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Aging; Cognition; Dementia; Functional status; G; Intelligence

Indexed keywords

AGED; AGING; DEMENTIA; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; AGING; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 85010618389     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.101091     Document Type: Article

References (67)

1. Royall DR, Palmer RF. Thrombopoietin is associated with d's intercept, and only in Non-Hispanic Whites. Alzheimers Dement (Amst). 2016; 3:35-42. doi: 10.1016/j.dadm.2016.02.003.
2. Royall DR, Palmer RF. Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline. Alzheimers Dement. 2013; 9:318-25. doi: 10.1016/j.jalz.2011.11.009
3. Gavett BE, John SE, Gurnani AS, Bussell CA, Saurman JL. The role of Alzheimer's and cerebrovascular pathology in mediating the effects of age, race, and apolipoprotein E genotype on dementia severity in pathologically confirmed Alzheimer's disease. J Alzheimers Dis. 2016; 49:531-45. doi: 10.3233/JAD-150252
4. Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, Abner EL, Smith CD, Van Eldik LJ, Kryscio RJ, Scheff SW. Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol. 2011; 121:571-87 doi: 10.1007/s00401-011-0826-y
5. Royall DR, Palmer RF. Aging is a weak but relentless determinant of dementia severity. Oncotarget. 2016; 7:13307-18. doi: 10.18632/oncotarget.7759.
6. Gavett BE, Vudy V, Jeffrey M, John SE, Gurnani AS, Adams JW. The d latent dementia phenotype in the uniform data set: cross-validation and extension. Neuropsychology. 2015; 29:344-52. doi: 10.1037/neu0000128
7. Palmer RF, Royall DR. Future dementia status is almost entirely explained by the latent variable d's intercept and slope. J Alzheimers Dis. 2016; 49:521-29 doi: 10.3233/JAD-150254
8. Royall DR, Palmer RF. d scores predict MCI and AD conversions from non-demented states. J Prev Alzheimers Dis. 2015a; 2:337-38. Abstract
9. von Guten A, Ebbing K, Imhof A, Giannakopoulos P, Kövari E. Brain aging in the oldest-old. Curr Gerontol Geriatr Res. 2010. pii: 358531. doi: 10.1155/2010/358531
10. Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014; 128:755-66. doi: 10.1007/s00401-014-1349-0
11. Bishnoi R, Palmer RF, Royall DR. Serum interleukin (IL)-15 as a biomarker of Alzheimer's disease. PLoS One. 2015; 10:e0117282. doi: 10.1371/journal.pone.0117282
12. Bishnoi RJ, Palmer RF, Royall DR. Vitamin D binding protein as a serum biomarker of Alzheimer's disease. J Alzheimers Dis. 2015; 43:37-45. doi: 10.3233/JAD-140042
13. Royall DR, Palmer RF. Ethnicity moderates dementia's biomarkers. J Alzheimers Dis. 2015; 43:275-87. doi: 10.3233/JAD-140264
14. Royall DR, Bishnoi RJ, Palmer RF. Serum IGF-BP2 strongly moderates age's effect on cognition: a MIMIC analysis. Neurobiol Aging. 2015; 36:2232-40. doi: 10.1016/j.neurobiolaging.2015.04.003
15. Royall DR, Palmer RF, Vidoni ED, Honea RA, Burns JM. The default mode network and related right hemisphere structures may be the key substrates of dementia. J Alzheimers Dis. 2012; 32:467-78. doi: 10.3233/JAD-2012-120424
16. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci USA. 2001; 98:676-82. doi: 10.1073/pnas.98.2.676
17. Andrews-Hanna JR, Snyder AZ, Vincent JL, Lustig C, Head D, Raichle ME, Buckner RL. Disruption of largescale brain systems in advanced aging. Neuron. 2007; 56:924-35. doi: 10.1016/j.neuron.2007.10.038
18. Damoiseaux JS, Beckmann CF, Arigita EJ, Barkhof F, Scheltens P, Stam CJ, Smith SM, Rombouts SA. Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex. 2008; 18:1856-64. doi: 10.1093/cercor/bhm207
19. Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, Smith SM, Beckmann CF, Adelstein JS, Buckner RL, Colcombe S, Dogonowski AM, Ernst M, Fair D, et al. Toward discovery science of human brain function. Proc Natl Acad Sci USA. 2010; 107:4734-39. doi: 10.1073/pnas.0911855107
20. Koch W, Teipel S, Mueller S, Buerger K, Bokde AL, Hampel H, Coates U, Reiser M, Meindl T. Effects of aging on default mode network activity in resting state fMRI: does the method of analysis matter? Neuroimage. 2010; 51:280-87. doi: 10.1016/j.neuroimage.2009.12.008
21. Lustig C, Snyder AZ, Bhakta M, O'Brien KC, McAvoy M, Raichle ME, Morris JC, Buckner RL. Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci USA. 2003; 100:14504-09. doi: 10.1073/pnas.2235925100
22. Grady CL, Springer MV, Hongwanishkul D, McIntosh AR, Winocur G. Age-related changes in brain activity across the adult lifespan. J Cogn Neurosci. 2006; 18:227-41. doi: 10.1162/jocn.2006.18.2.227
23. Thompson WH, Thelin EP, Lilja A, Bellander BM, Fransson P. Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury. Neuroimage Clin. Epub ahead of print.
24. Ali MS, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth. 2000; 85:287-98. doi: 10.1093/bja/85.2.287
25. Lian H, Yang L, Cole A, Sun L, Chiang AC, Fowler SW, Shim DJ, Rodriguez-Rivera J, Taglialatela G, Jankowsky JL, Lu HC, Zheng H. NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease. Neuron. 2015; 85:101-15. doi: 10.1016/j.neuron.2014.11.018
26. Le Roith D. The insulin-like growth factor system. Exp Diabesity Res. 2003; 4:205-12. doi: 10.1155/EDR.2003.205
27. Berryman DE, Christiansen JS, Johannsson G, Thorner MO, Kopchick JJ. Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res. 2008; 18:455-71. doi: 10.1016/j.ghir.2008.05.005
28. Hoffman AR, Pyka G, Lieberman SA, Ceda GP, Marcus R. The somatopause. In: Muller EE, Cocchi D, Locatelli V, eds. Growth hormone and somatomedins during lifespan. Berlin: Springer Verlag, 1993.
29. Hu D, Pawlikowska L, Kanaya A, Hsueh WC, Colbert L, Newman AB, Satterfield S, Rosen C, Cummings SR, Harris TB, Ziv E, and Health, Aging, and Body Composition Study. Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study. J Am Geriatr Soc. 2009; 57:1213-18. doi: 10.1111/j.1532-5415.2009.02318.x
30. Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML, Van der Veen EA, Koppeschaar HP. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab. 1999; 84:471-75. doi: 10.1210/jcem.84.2.5455
31. Aleman A, Torres-Alemán I. Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog Neurobiol. 2009; 89:256-65. doi: 10.1016/j.pneurobio.2009.07.008
32. Camargo EC, Weinstein G, Beiser AS, Tan ZS, DeCarli C, Kelly-Hayes M, Kase C, Murabito JM, Seshadri S. Association of physical function with clinical and subclinical brain disease: The Framingham Offspring Study. J Alzheimers Dis. 2016; 53:1597-608. doi: 10.3233/JAD-160229
33. Panza F, Solfrizzi V, Barulli MR, Santamato A, Seripa D, Pilotto A, Logroscino G. Cognitive Frailty: A systematic review of epidemiological and neurobiological evidence of an age-related clinical condition. Rejuvenation Res. 2015; 18:389-412. doi: 10.1089/rej.2014.1637
34. McAdory BS, Van Eldik LJ, Norden JJ. S100B, a neurotropic protein that modulates neuronal protein phosphorylation, is upregulated during lesioninduced collateral sprouting and reactive synaptogenesis. Brain Res. 1998; 813:211-17. doi: 10.1016/S0006-8993(98)01014-2
35. Tournell CE, Bergstrom RA, Ferreira A. Progesteroneinduced agrin expression in astrocytes modulates glia-neuron interactions leading to synapse formation. Neuroscience. 2006; 141:1327-38. doi: 10.1016/j.neuroscience.2006.05.004
36. Deak F, Sonntag WE. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J Gerontol A Biol Sci Med Sci. 2012; 67:611-25. doi: 10.1093/gerona/gls118
37. Cho H, Joo Y, Kim S, Woo RS, Lee SH, Kim HS. Plasminogen activator inhibitor-1 promotes synaptogenesis and protects against aβ(1-42)-induced neurotoxicity in primary cultured hippocampal neurons. Int J Neurosci. 2013; 123:42-49 doi: 10.3109/00207454.2012.724127
38. Mastellos DC. Complement emerges as a masterful regulator of CNS homeostasis, neural synaptic plasticity and cognitive function. Exp Neurol. 2014; 261:469-74. doi: 10.1016/j.expneurol.2014.06.019
39. Ronan T, Macdonald-Obermann JL, Huelsmann L, Bessman NJ, Naegle KM, Pike LJ. Different Epidermal Growth Factor Receptor (EGFR) agonists produce unique signatures for the recruitment of downstream signaling proteins. J Biol Chem. 2016; 291:5528-40. doi: 10.1074/jbc.M115.710087
40. Kesler SR. Default mode network as a potential biomarker of chemotherapy-related brain injury. Neurobiol Aging. 2014 (Suppl 2); 35:S11-19. doi: 10.1016/j.neurobiolaging.2014.03.036
41. Wang X-M, Walitt B, Saligan L, Tiwari AF, Cheung CW, Zhang Z-J. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine. 2015; 72:86-96. doi: 10.1016/j.cyto.2014.12.006
42. Small BJ, Scott SB, Jim HS, Jacobsen PB. Is cancer a risk factor of cognitive decline in late life? Gerontology. 2015; 61:561-66. doi: 10.1159/000381022
43. Zhang Q, Guo S, Zhang X, Tang S, Shao W, Han X, Wang L, Du Y. Inverse relationship between cancer and Alzheimer's disease: a systemic review metaanalysis. Neurol Sci. 2015; 36:1987-94. doi: 10.1007/s10072-015-2282-2
44. Adriaensen W, Matheï C, Vaes B, van Pottelbergh G, Wallemacq P, Degryse JM. Interleukin-6 predicts short-term global functional decline in the oldest old: results from the BELFRAIL study. Age (Dordr). 2014; 36:9723. doi: 10.1007/s11357-014-9723-3
45. Wechsler D. Wechsler Memory Scale-Third Edition. San Antonio, TX: The Psychological Corporation, 1997.
46. Benton A, Hamsher K. Multilingual Aphasia Examination. AJA Associates, Iowa City, Iowa, 1989.
47. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9:179-86. doi: 10.1093/geront/9.3_Part_1.179
48. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140:566-72. doi: 10.1192/bjp.140.6.566
49. Waring S, O'Bryant SE, Reisch JS, Diaz-Arrastia R, Knebl J, Doody R; for the Texas Alzheimer's Research Consortium. The Texas Alzheimer's Research Consortium longitudinal research cohort: study design and baseline characteristics. Texas Public Health Journal. 2008; 60:9-13.
50. Koch W, Ehrenhaft A, Griesser K, Pfeufer A, Müller J, Schömig A, Kastrati A. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med. 2002; 40:1123-31. doi: 10.1515/cclm.2002.197
51. Arbuckle JL. Analysis of Moment Structures-AMOS (Version 7.0) [Computer Program], SPSS, Chicago, 2006.
52. Grice JW. Computing and evaluating factor scores. Psychol Methods. 2001; 6:430-50. doi: 10.1037/1082-989X.6.4.430
53. Spearman C, Wynn Jones LL. Human Ability, Macmillan & Co., London, 1951.
54. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry. 2001; 158:848-56 doi: 10.1176/appi.ajp.158.6.848
55. MacKinnon D. Analysis of mediating variables in prevention and intervention research. In: Czarees A, Beatty L (editors). Scientific methods for prevention intervention research. NIDA Research Monograph. 1994;139:137-153.
56. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978; 8:283-98. doi: 10.1016/S0001-2998(78)80014-2
57. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993; 39:561-77.
58. Palmer RF, Royall DR. Missing data? Plan on it! J Am Geriatr Soc. 2010 (Suppl 2); 58:S343-48. doi: 10.1111/j.1532-5415.2010.03053.x
59. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002; 7:147-77. doi: 10.1037/1082-989X.7.2.147
60. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009; 60:549-76. doi: 10.1146/annurev.psych.58.110405.085530
61. Statistics PA. 18, Release Version 18.0.0, SPSS, Inc., 2009, Chicago, IL.
62. Bollen KA, Long JS. Testing Structural Equation Models. Sage Publications, Thousand Oaks, CA, 1993.
63. Wheaton B, Muthén B, Alwin DF, Summer GF. Assessing reliability and stability in panel models. In D.R.Heise (Ed.) Sociology Methodology San Francisco, CA: Jossey-Bass, 1977.
64. Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990; 107:238-46. doi: 10.1037/0033-2909.107.2.238
65. Browne M, Cudeck R. Alternative ways of assessing model fit. In Testing structural equation models, Bollen KA, Long JS, eds. Sage Publications, Thousand Oaks, CA, pp. 136-162, 1993.
66. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: A preliminary report. J Am Geriatr Soc. 1982; 29:164-71. doi: 10.1111/j.1532-5415.1981.tb01759.x
67. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-98. doi: 10.1016/0022-3956(75)90026-6